cas 2380061-33-4|| where to buy 1-({1-[(4-chlorophenyl)methyl]-1H-1,2,3-triazol-4-yl}methyl)-4-(4-fluorophenyl)-1,2,3,4-tetrahydropyrazine-2,3-dione

Nombre del producto:1-({1-[(4-chlorophenyl)methyl]-1H-1,2,3-triazol-4-yl}methyl)-4-(4-fluorophenyl)-1,2,3,4-tetrahydropyrazine-2,3-dione

IUPAC Name:1-({1-[(4-chlorophenyl)methyl]-1H-1,2,3-triazol-4-yl}methyl)-4-(4-fluorophenyl)-1,2,3,4-tetrahydropyrazine-2,3-dione

: CAS：2380061-33-4; Fórmula molecular：C20H15ClFN5O2; Pureza：95%+

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2380061-33-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2380061-33-4; Fórmula molecular:C20H15ClFN5O2; Punto de fusión:-; Código de sonrisas:FC1=CC=C(C=C1)N1C=CN(CC2=CN(CC3=CC=C(Cl)C=C3)N=N2)C(=O)C1=O; Densidad:

: Número de catálogo:CM785125; Peso molecular:411.82; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyrazines; Pyrazine is a heterocyclic aromatic organic compound with chemical formula C4H4N2. The marketed pyrazine drugs are mainly distributed in the field of anti-tumor and anti-infection. In recent years, there have been many new drugs in various fields, and there are some new target drugs worthy of attention.; pyrazine,pyrazine price; if you want to know the latest news about pyrazine and pyrazine price, please come to our website and get a quote for free.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.